Shuttle Pharmaceuticals
SHPH
3 hedge funds and large institutions have $38.8K invested in Shuttle Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
0% more funds holding
Funds holding: 3 → 3 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
76% less capital invested
Capital invested by funds: $158K → $38.8K (-$120K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$14.3K |
| 2 |
VF
Virtu Financial
New York
|
+$10.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$1.02K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Geode Capital Management
Boston,
Massachusetts
| $16.5K | – | – | – |
|
|
2
Renaissance Technologies
New York
| $13K | +$14.3K | +14 | New |
|
|
VF
3
Virtu Financial
New York
| $9K | +$10.2K | +10 | New |
|
|
FDCDDQ
4
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $228 | -$1.02K | -1 | Closed |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $46 | – | – | – |
|
6
Wells Fargo
San Francisco,
California
| $24 | – | – | – |
|
SHPH Hedge Fund Activity: Q4 2023 in Review
3 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Shuttle Pharmaceuticals (SHPH) for Q4 2023, worth a combined $38.8K — down 76% from $158K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new SHPH positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $14.3K. The largest seller was Federation des caisses Desjardins du Quebec, exiting entirely with an estimated $1.02K sold.
- 3 institutional investors held Shuttle Pharmaceuticals (SHPH) as of Q4 2023, unchanged from Q3 2023.
- Funds reported $38.8K of Shuttle Pharmaceuticals stock for Q4 2023, down 76% quarter-over-quarter.
- 2 funds opened new Shuttle Pharmaceuticals positions in Q4 2023 and 1 closed out, a net change of +1 holder.
- The largest Shuttle Pharmaceuticals buyer in Q4 2023 was Renaissance Technologies, an estimated $14.3K added.
- The largest Shuttle Pharmaceuticals seller in Q4 2023 was Federation des caisses Desjardins du Quebec, an estimated $1.02K sold.
Based on aggregated 13F filings for Q4 2023.